Literature DB >> 17332929

Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix.

Sonali P Barwe1, Raymond S Maul, Jason J Christiansen, Gopalakrishnapillai Anilkumar, Carlton R Cooper, Donald B Kohn, Ayyappan K Rajasekaran.   

Abstract

Prostate specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed almost exclusively in prostatic epithelial cells. Expression of PSMA is elevated in prostate cancer, with levels closely correlated with disease grade. Although the highest levels of PSMA expression are associated with high-grade, hormone-refractory and metastatic prostate cancer, the significance of elevated PSMA expression in advanced prostate cancer has yet to be fully elucidated. We provide evidence that prostatic carcinoma cells expressing PSMA exhibit reduced motility and increased attachment when grown on a bone marrow matrix substrate. This phenomenon occurs via activation of focal adhesion kinase and provides the first evidence of a link between PSMA expression and prostate cancer metastasis to the bone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332929

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

Review 1.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Bispecific antibodies: a novel approach for targeting prominent biomarkers.

Authors:  Akshita Gupta; Yatender Kumar
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

3.  N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.

Authors:  Ronnie C Mease; Crystal L Dusich; Catherine A Foss; Hayden T Ravert; Robert F Dannals; Jurgen Seidel; Andrew Prideaux; James J Fox; George Sgouros; Alan P Kozikowski; Martin G Pomper
Journal:  Clin Cancer Res       Date:  2008-05-15       Impact factor: 12.531

Review 4.  Prostate-specific membrane antigen as a target for cancer imaging and therapy.

Authors:  A P Kiess; S R Banerjee; R C Mease; S P Rowe; A Rao; C A Foss; Y Chen; X Yang; S Y Cho; S Nimmagadda; M G Pomper
Journal:  Q J Nucl Med Mol Imaging       Date:  2015-07-24       Impact factor: 2.346

5.  The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways.

Authors:  Marco Colombatti; Silvia Grasso; Alessandra Porzia; Giulio Fracasso; Maria Teresa Scupoli; Sara Cingarlini; Ornella Poffe; Hassan Y Naim; Martin Heine; Giuseppe Tridente; Fabrizio Mainiero; Dunia Ramarli
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

6.  Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice.

Authors:  Liang-Yun Zhao; Xiao-Peng Mao; Kai-Yuan Chao; Sheng-Jie Guo; Shao-Peng Qiu
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.